Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Authentrics.ai Accelerates Trusted AI at Scale and Is Now Available on Google Cloud Marketplace
-
Future Technologies Expands Leadership with Appointment of Mary Peterson as Chairperson of Advisory Board
-
Form 8.3 - AXA INVESTMENT MANAGERS: PRS REIT Plc
-
Shine, baby, shine: Solar energy is fuelling the energy transition at high speed
-
Form 8.3 - Empiric Student Property Plc
-
Unicycive Therapeutics Provides Update from FDA Type A Meeting and Expects to Resubmit OLC NDA Before Year-End
-
Skyworks Reports Preliminary Q4 and Full Year FY25 Results
-
Skyworks and Qorvo to Combine to Create $22 Billion U.S.-Based Leader in High-Performance RF, Analog and Mixed-Signal Solutions
-
Invivyd to Host Webcast on the REVOLUTION Clinical Program for VYD2311, a Vaccine-Alternative Antibody to Prevent COVID
-
Abcourt obtains its environmental certificate of authorization for custom milling at the Sleeping Giant Mill
-
Amphista Therapeutics to showcase how its Targeted Glue™ technology is expanding the diversity of TPD medicines at the 8th Annual TPD & Induced Proximity Summit 2025
-
Zag Bio™ Launches with $80 Million Financing to Advance Thymus-targeted Medicines for Autoimmune Diseases
-
Tonix Pharmaceuticals Announces Presentation at BIO-Europe 2025
-
Lifecore and PolyPeptide Announce Collaboration Intended to Offer End-to-End Peptide Manufacturing Solution for U.S. Market
-
Kaixin Holdings Announces Intended Acquisition of Honglu Technology to Optimize AI Applications
-
YourUpdateTV speaks with Mia Syn: FALL FAMILY RESET: EASY NUTRITION & LIFESTYLE STRATEGIES TO KEEP FAMILIES THRIVING ALL SEASON LONG
-
Bioventus to Report Third Quarter of Fiscal Year 2025 Financial Results on November 4, 2025
-
Kymera Therapeutics to Report Third Quarter 2025 Financial Results on November 4, 2025
-
Ocular Therapeutix™ to Report Third Quarter 2025 Financial Results on November 4, 2025
-
AOI Announces Expansion in the City of Sugar Land
-
Americold Ireland Achieves Exclusive U.S. Meat Export Certification and Five AA-Rated Audits, Reinforcing Global Cold Chain Leadership
-
ONL Therapeutics Announces Randomization of First Patient in Global Phase 2 GALAXY Trial of Xelafaslatide (ONL1204) in Patients with Geographic Atrophy (GA) Associated with Dry AMD
-
Koryx Copper Announces Further Positive Drill Results at the Haib Copper Project, Southern Namibia
-
Prospect Capital Corporation Announces Pricing of $167 Million 5.5% Oversubscribed Institutional Unsecured Notes Offering
-
Qorvo® Announces Preliminary Fiscal 2026 Second Quarter Financial Results
-
Laurette T. Koellner Rejoins Celestica’s Board of Directors
-
Chijet Motor Company Forges Transformative Exclusive Partnership with Singapore-Backed Tagvance to Pioneer Global Autonomous Driving Revolution
-
Safe and Green Holdings Announces Its 2025 Record Date and Annual Shareholders Meeting Date
-
FrontlineIQ Emerges from Stealth with $3.3M in Funding to Lead a New Era of AI Coaching for In-Person Sales
-
Creative Realities Wins 2025 DIZZIE Award for Digital Transformation at Rogers Arena
-
CECO Environmental Reports Third Quarter 2025 Results
-
Verano Holdings Corp. Announces Shareholder Approval to Redomicile Parent Company from British Columbia to Nevada
-
Castle Biosciences to Participate in Upcoming Investor Conferences
-
Entrada Therapeutics to Present at Upcoming Investor Conferences
-
Climb Channel Solutions Announces North American Partnership with Halcyon
-
Stella-Jones to Hold Investor Day
-
EVgo to Report Third Quarter 2025 Results on November 10
-
Nutriband Announces Successful Meeting Completed With United States FDA For Its Abuse Deterrent Fentanyl Patch
-
Causeway Therapeutics Debuts Positive Data from Phase 2 Clinical Trial of TenoMiR® for Lateral Epicondylitis
-
Aeluma Acquires Significant Capital Equipment Assets to Accelerate Manufacturing Readiness
-
YourUpdateTV speaks with Mia Syn: FALL FAMILY RESET: EASY NUTRITION & LIFESTYLE STRATEGIES TO KEEP FAMILIES THRIVING ALL SEASON LONG
-
CW Petroleum Corp (OTCQB: CWPE) Reports Revenues for Q3-2025
-
Sitryx presents new preclinical data highlighting MTHFD2 as a novel metabolic target in autoimmune disease at ACR Convergence 2025
-
Amphista Therapeutics to showcase how its Targeted Glue™ technology is expanding the diversity of TPD medicines at the 8th Annual TPD & Induced Proximity Summit 2025
-
AC Immune Appoints Renowned Neurologist Catherine Mummery as Chair of Clinical Advisory Board
-
BRKZ to accelerate KSA construction industry with new $30m finance facility as mega projects take off
-
GHO Capital announces final close of Fund IV with over €2.5bn of capital to continue investing in its strategy of driving better, faster and more accessible healthcare
-
YieldMax® ETFs Announces Weekly Distributions for Group 1 ETFs
-
RentRedi Adds Maintenance Chat, Setting New Standard for Rental Communications
-
Form 8.3 - AXA INVESTMENT MANAGERS: JTC Plc
